[HTML][HTML] The blood proteome of imminent lung cancer diagnosis
Nature communications, 2023 - nature.com
Identification of risk biomarkers may enhance early detection of smoking-related lung
cancer. We measured between 392 and 1,162 proteins in blood samples drawn at most …
cancer. We measured between 392 and 1,162 proteins in blood samples drawn at most …
[HTML][HTML] Catching Cancer Early: The Importance of Dermato-Oncology Screening
Simple Summary Skin cancers, either melanocytic (malignant melanoma) or nonmelanocytic
(squamous cell carcinoma, basal cell carcinoma), unlike most types of cancers which are not …
(squamous cell carcinoma, basal cell carcinoma), unlike most types of cancers which are not …
[HTML][HTML] Correlation Studies between S100 Protein Level and Soluble MIA or Tissue MelanA and gp100 (HMB45) Expression in Cutaneous Melanoma
(1) Background: Cutaneous melanoma (CM) originates from melanocytes and causes 90%
of skin cancer deaths; therefore, the comparison of different soluble and tissue markers …
of skin cancer deaths; therefore, the comparison of different soluble and tissue markers …
[HTML][HTML] Immune checkpoint inhibitors in metastatic melanoma therapy
V Shah, V Panchal, A Shah… - Medicine …, 2024 - … .spandidos-publications.com
An increase in the incidence of melanoma has been observed in recent decades, which
poses a significant challenge due to its poor prognosis in the advanced and metastatic …
poses a significant challenge due to its poor prognosis in the advanced and metastatic …
[Retracted] Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S‐100B Protein in Patients with Malignant Melanoma
S Fan, X Liu, Y Wu, K Li, X Zhao… - Evidence‐Based …, 2022 - Wiley Online Library
Objective. This investigation probed the prognostic potential for lactate dehydrogenase
(LDH), melanoma inhibitory activity protein (MIA), and S‐100B protein in cases of malignant …
(LDH), melanoma inhibitory activity protein (MIA), and S‐100B protein in cases of malignant …
Aggregation-induced signal amplification strategy based on peptide self-assembly for ultrasensitive electrochemical detection of melanoma biomarker
The detection of melanoma circulating biomarker in liquid biopsies is current under
evaluation for being potentially utilized for earlier cancer diagnosis and its metastasis …
evaluation for being potentially utilized for earlier cancer diagnosis and its metastasis …
[HTML][HTML] Metastatic multifocal melanoma of multiple organ systems: A case report
V Maksimaityte, R Reivytyte, G Milaknyte… - World journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Malignant melanoma is becoming more common among middle-aged
individuals all over the world. Melanoma metastasis can be found in various organs …
individuals all over the world. Melanoma metastasis can be found in various organs …
[HTML][HTML] Combining Biomarkers for the Diagnosis of Metastatic Melanoma
The early detection of melanoma relapse can improve patient survival; thus, there is a great
need for easily accessible biomarkers that facilitate the diagnosis of metastatic disease. We …
need for easily accessible biomarkers that facilitate the diagnosis of metastatic disease. We …
[HTML][HTML] Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma …
Background Prognostic classification of metastatic melanoma patients treated with anti-PD-1
is of great interest to clinicians. Objective We aimed to determine the anti-PD-1 treatment …
is of great interest to clinicians. Objective We aimed to determine the anti-PD-1 treatment …
Histopathology-assisted proteogenomics provides foundations for stratification of melanoma metastases
Here we describe the histopathology-driven proteogenomic landscape of 142 treatment-
naive metastatic melanoma samples. We identified five proteomic subtypes that integrate the …
naive metastatic melanoma samples. We identified five proteomic subtypes that integrate the …